Reimagining the Clinical Trial Experience


54 min



The costs of lost NIH-funded research alone due to COVID-19 is more than $10B. While there are no specific cost numbers from private clinical trials, nearly 1,200 clinical trials were either stopped or delayed due to COVID-19. Suspended enrollment was the root of many of these issues and with the cost of delay estimated between $600K-$8M a day in subsequent sales, the need to restart the trials and put patients back at their center is critical.

Key industry stakeholders have now seen the acute need to accelerate their adoption of virtual clinical trials. When it comes to clinical trials, adopting this model ensures future clinical trial continuity regardless of seen, or unseen, disruptions.

This digital event explains the key elements you need to set up and scale your digital health strategy successfully. You’ll learn how to expedite the move to virtual clinical trials with a modern digital infrastructure.

Gain insight into best practices for managing the expectations of sponsors, investigators, CROs, and patients. In addition, we detail how a purpose-built platform can create greater efficiencies and streamline key processes, which means you’ll achieve your clinical trial goals more quickly, with less risk and at a lower cost.

Watch and discover how to put patients back at the center of your clinical trials by integrating digital technologies into the clinical trial process.


Our speakers:

Mariya Boychuk

Mariya Boychuk, Business Analyst Healthcare Solutions

Mariya Boychuk is a Senior Business Analyst at SoftServe with over 10 years of experience in the healthcare and life science domains. She works closely with partner companies to evaluate new business concepts, elicit requirements, and manage risks.
Steve LoSardo

Steve LoSardo, Vice President of Life Science Solutions and Consulting

Steve LoSardo is a dynamic leader and visionary with more than 25 years of experience providing information technology solutions to consumers, life science, and healthcare companies. Steve recently joined SoftServe as Vice President of Life Science Solutions and Consulting. His focus is on working with clients to deliver innovative digital solutions based on Web, Mobile, Voice, IoT, Big Data, AI/ML, and Cloud technologies in the pharma, biotech, medical device, provider, and payer space. Before joining SoftServe, Steve held leadership roles at Mobiquity (a Hexaware Technologies company), IMSHealth, PricewaterhouseCoopers, and Verispan, a joint venture between Quintiles Transnational and McKesson focused on healthcare information technology.

Доступ до вебінару

Щоб отримати інформацію про те, що ми робимо з Вашими особистими даними, перегляньте нашу Політику приватності.